In focus · trending topic

pregnancy

30 stories · following the connections

Agile Therapeutics Announces Proposed Offering of Common Stock

By Nasdaq OMXAug 2, 2017, 8:06 PM UTC

Agile Therapeutics Reports Second Quarter 2017 Financial Results

By Nasdaq OMXJul 28, 2017, 11:30 AM UTC

Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®

By Nasdaq OMXJul 27, 2017, 8:12 PM UTC

Babyscripts Raises $5.7 Million to Build the Market's Most Robust, Clinically-Validated Virtual Care Women's Health Platform

By Nasdaq OMXJun 29, 2017, 1:00 PM UTC

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Contraceptive Patch, Twirla®

By Nasdaq OMXJun 27, 2017, 12:00 PM UTC

Agile Therapeutics Announces Results of its Pre-Submission Meeting with FDA

By Nasdaq OMXApr 11, 2017, 11:00 AM UTC

CARE OF PATIENTS PRE, PERI AND POST PREGNANCY ADDRESSED DURING 37th ANNUAL ISHLT MEETING & SCIENTIFIC SESSIONS

By Nasdaq OMXApr 8, 2017, 2:30 PM UTC

Agile Therapeutics Announces a Poster Presentation of its SECURE Phase 3 Study at the Contraceptive Technology 2017 Conference

By Nasdaq OMXMar 16, 2017, 8:30 PM UTC